NewEdge Wealth LLC Has $5.58 Million Stake in Danaher Co. (NYSE:DHR)

NewEdge Wealth LLC trimmed its holdings in shares of Danaher Co. (NYSE:DHR) by 0.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,300 shares of the conglomerate’s stock after selling 113 shares during the period. NewEdge Wealth LLC’s holdings in Danaher were worth $5,578,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Bryn Mawr Capital Management LLC increased its stake in shares of Danaher by 1.3% in the 4th quarter. Bryn Mawr Capital Management LLC now owns 73,314 shares of the conglomerate’s stock valued at $16,829,000 after buying an additional 908 shares during the period. Fjell Capital LLC acquired a new stake in shares of Danaher in the 4th quarter valued at $454,000. Cutter & CO Brokerage Inc. increased its stake in shares of Danaher by 3.1% in the 4th quarter. Cutter & CO Brokerage Inc. now owns 2,217 shares of the conglomerate’s stock valued at $509,000 after buying an additional 66 shares during the period. Lake Street Advisors Group LLC increased its stake in shares of Danaher by 1.2% in the 4th quarter. Lake Street Advisors Group LLC now owns 5,967 shares of the conglomerate’s stock valued at $1,371,000 after buying an additional 71 shares during the period. Finally, JFG Wealth Management LLC acquired a new stake in shares of Danaher in the 4th quarter valued at $315,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Barclays decreased their price objective on Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Raymond James reaffirmed a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective for the company in a research note on Friday, December 13th. Finally, Scotiabank assumed coverage on Danaher in a research note on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price objective for the company. Seven equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Trading Down 1.8 %

Shares of DHR stock opened at $205.69 on Friday. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The stock has a market cap of $147.01 billion, a P/E ratio of 38.96, a price-to-earnings-growth ratio of 2.66 and a beta of 0.83. The stock has a 50 day simple moving average of $225.00 and a 200 day simple moving average of $245.50. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70.

Danaher (NYSE:DHR) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the firm earned $2.09 earnings per share. On average, research analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.62%. Danaher’s dividend payout ratio is presently 24.24%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.